Dr. Joseph M. Chalil is a prominent physician executive, currently serving as the Chief Medical Officer at Novo Integrated Sciences, Inc. His extensive contributions to healthcare innovation and research are recognized internationally, with numerous publications in leading journals.
Dr. Chalil is also an LLM Medical Law and Ethics candidate at the University of Edinburgh Law School, further enhancing his expertise in the intersection of healthcare, law, and ethics.
He holds key positions as the Chairman of the Complex Health Systems Advisory Board and as an Adjunct Professor at the College of Business at Nova Southeastern University, Florida. His influential book, “Beyond the Covid-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare,” reflects his vision and commitment to advancing global healthcare systems.
A U.S. Navy Medical Corps veteran, Dr. Chalil is also a strategic member of the Executive Leadership Council at the Dr. Kiran C. Patel College of Allopathic Medicine. He serves as the Chief Strategic Advisor for the American Association of Physicians of Indian Origin (AAPI), advocating for the interests of Indian-origin medical professionals.
Dr. Chalil is a Fellow of the American College of Healthcare Executives and is recognized for his leadership in healthcare administration. His commitment to balanced media representation is evident from his tenure as Chairman of the Indo-American Press Club and as a columnist for the Sunday Guardian. He is also a regular guest on Indian TV news channels like Republic TV and NewsX, where he discusses various topics, including US-India relations, geopolitical issues, and public policy, showcasing his depth of knowledge in these areas.
His unique blend of medical, legal, and policy expertise positions Dr. Chalil as a respected figure in healthcare and media. He is admired for his contributions to patient-centered care, healthcare policy, and international relations.
Education
Chalil completed his Bachelor of Medicine and Bachelor of Surgery from JJM Medical College, Davengere, India, in 1998 [9]. In 2004, he obtained a Master of Business Administration from Davenport University, Michigan [4]. In the same year, he completed a certification in Pharmaceutical Management from CMR Institute. He was awarded Fellowship by the American College of Healthcare Executives in 2009. He also completed Global Health Delivery Certification from Harvard University in 2021.
University of Edinburgh Law School
Master of Laws – LLM Candidate in Medical Law & Ethics (2023 – 2025)
Harvard University
American College of Healthcare Executives
Davenport University
Henry Ford Hospital
JJM Medical College
JJM Medical College (1998), Davengere, India (M.B.B.S., Bachelor of Medicine and Bachelor of Surgery)
Career
- Chief Medical Officer of Novo Integrated Sciences, Inc. (NYSE: NVOS)
- Chief Strategic Adviser, American Association of Physicians of Indian Origin (AAPI)
- President, NovoAmerica Health Group.
- President, Clinical Consultants International, LLC
- Adjunct Professor and Chairman, Health System Advisory Board, College of Business & Entrepreneurship at Nova Southeastern University in Florida.
- Member of Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) Executive Leadership Council.
- Publisher of The Universal News Network and TheUNN.com
Dr. Joseph M. Chalil
MD, MBA, FACHE
Global Healthcare Executive and Best-Selling Author
![](https://drchalil.com/wp-content/uploads/2023/12/Dr.-Joseph-M-Chalil-Signature.jpg)
Education:
- University of Edinburgh Law School (Master of Laws - LLM Candidate in Medical Law & Ethics: 2023 - 2025)
- Harvard University (2021), Boston, MA, USA (Public Health, Global Healthcare Delivery Certification)
- American College of Healthcare Executives (2009), Chicago, IL, USA (FACHE, Fellowship)
- Davenport University (2004), Michigan, USA (MBA, Healthcare Administration)
- Henry Ford Hospital (2003), Detroit, MI USA (Hospital Administration Fellowship)
- JJM Medical College (1998), Davengere, India (M.B.B.S., Bachelor of Medicine and Bachelor of Surgery)
Title:
- Chief Medical Officer of Novo Integrated Sciences, Inc. (NYSE: NVOS)
- Chief Strategic Adviser, American Association of Physicians of Indian Origin (AAPI)
- President, NovoAmerica Health Group.
- President, Clinical Consultants International, LLC
- Adjunct Professor and Chairman, Health System Advisory Board, College of Business & Entrepreneurship at Nova Southeastern University in Florida.
- Member of Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) Executive Leadership Council.
- Publisher of The Universal News Network and TheUNN.com
Awards:
- AAPI Presidential Award for Leadership 2023
- Top Physician of the Year for 2022 by IAOTP
- AAPI Presidential Award for Leadership 2015
- 2013 Outstanding Top 50 Asian Americans in Business Award
- New York Presidential Award - American Association of Physicians of Indian Origin (AAPI) regional conference in Westbury, New York (2013)
- American Association of Cardiologists of Indian Origin (AACIO) Honoree (2013)
- Boehringer Ingelheim President's Club winner for 2011 and 2014.
#BurningQuestion | Ram Mandir float in NYC’s India Day parade stirs controversy
"This is not an Indian government-sponsored parade. This parade will be successful. Unfortunately, Democratic party has been hijacked by fringe elements," says Dr. Joseph Chalil (@Dr_Chalil),…
"This is a sad day for democracies": Dr. Joseph Chalil, Author and Publisher of Universal News Network
The Debate on #SuperprimetimeMax with Arnab is now #LIVE, on-air, and online.
Tune in and fire in your views - https://youtube.com/watch?v=UExxy2Q_9u4
#SheikhHasina #Bangladesh…
Indo-American Press Club Announces Board of Directors for 2024 And Beyond – Dr. Joseph Chalil Will Serve as the Chairman of BOD
Indo-American Press Club Announces Board of Directors for 2024 And Beyond – Dr. Joseph Chalil Will...
(New York, NY: August 4, 2024) Indo-American Press Club, the largest organization of media personnel of Indian origi...
theunn.com
Secret Service Director Kimberly Cheatle resigned amid bipartisan outrage over her agency’s failure to stop a 20-year-old gunman from opening fire on former President Donald Trump via @WSJ
Secret Service Director Resigns Amid Anger Over Trump Shooting
www.wsj.com
A New Chapter in Russia-India Relations: PM Modi’s Moscow Visit and Its Strategic Implications https://theunn.com/a-new-chapter-in-russia-india-relations-pm-modis-moscow-visit-and-its-strategic-implications/
🎓 Proud to be pursuing my LLM in Medical Law & Ethics at the University of Edinburgh, ranked in the top 10 globally! Honored to be part of such a prestigious program, furthering my expertise in healthcare, law, and ethics. 🌍📚 #EdinburghLLM #HealthcareLaw #MedicalEthics…
Books, Publications and Patents
A strong proponent of providing healthcare access for everyone, Chalil’s new book Beyond the COVID-19 Pandemic stands out because It goes on to propose non-partisan solutions to reform U.S. Healthcare [1][7]. The book discusses how advances in and the adoption of new technology will revolutionize healthcare, offering critical strategies that countries can adopt during natural disasters, wars, or pandemics. The authors envision the emerging world order addressing healthcare needs, education, and sustainable lifestyle choices, reducing the need for more intensive and costly interventions to improve the overall quality of life.
Patents
- United States Patent granted on January 24, 2012, to Joseph M. Chalil – Inventor – Patent No. US 8,101,469. Method of Forming Monolithic CMOS-MEMS Hybrid Integrated, Packaged Structures, 21 Claims. (The invention relates to a method of integrating MEMS and CMOS structures. Monolithic integration of MEMS/NEMS and electronics offers significant benefits, enabling high-volume production and significantly driving down the per-unit costs of sensor and actuator systems.)
- United States Patent granted on January 24, 2012, to Joseph M. Chalil – Inventor – Patent No. US 8,101,458. Method of Forming Monolithic CMOS-MEMS Hybrid Integrated, Packaged Structures, 15 Claims.
- United States Patent granted on August 2, 2011, to Joseph M. Chalil – Inventor – Patent No. US 7,989,248. Method of Forming Monolithic CMOS-MEMS Hybrid Integrated, Packaged Structures, 40 Claims.
- K. Kumar, Joseph Chalil, et al. (2011): World Intellectual Property Organization International Bureau Worldwide patent No. WO2011003057A2. Procédé de formation de structures intégrées et empilées hybrides de mems cmos monolithiques
- K. Kumar, Joseph Chalil, et al. (2011): World Intellectual Property Organization International BureauWorldwide patent No. WO2011003057A3. Procédé de formation de structures intégrées et empilées hybrides de mems cmos monolithiques
- K. Kumar, Joseph Chalil, et al. (2009): U.S. Patent Application No. 12/547, 191. Flexible Penetrating Electrodes For Neuronal Stimulation and Recording and Method of Manufacturing Same. (The invention relates to penetrating electrodes and a method of producing flexible, penetrating multi-electrode arrays for neuronal applications.)
- K. Kumar, Joseph Chalil, et al. (2009): U.S. Provisional Patent Application No.61/237,407. Intelligent CMOS MEMS Drug Delivery System. (The device senses intra-cardiac pressure and, depending upon the sensed pressure, directs the electronic module to deliver a specified dosage of a drug.)
Books & Publications
- Pradeep Kapur and Joseph Chalil. Beyond the COVID-19 Pandemic: Envisioning a Better World by transforming the Future of Healthcare. 2020 October 5
- Greenhawt M, Abrams EM, Chalil JM, et al. The Impact of Allergy Specialty Care on Health care utilization among Peanut Allergy Children in the United States. The Journal of Allergy & Clinical Immunology in Practice. 2022;10(12):3276-3283.
- Miller TA, Koppelman SJ, Chalil JM, et al. Peanut cross-contamination in randomly selected baked goods. Ann Allergy Asthma Immunol. 2022;128(4):439-442.
- Shaker M, Chalil JM, et al. Commercial claims costs related to healthcare resource use associated with a diagnosis of peanut allergy. Ann Allergy Asthma Immunol. 2020;124(4):357365.e1.
- Marcus Shaker, Joseph M. Chalil et al. Economic Burden of Disease Among Peanut-Allergic Children.Ann Allergy Asthma Immunol. 2019 Nov;123(5): S19-S62. P302
- Terri Brown-Whitehorn, Joseph M. Chalil et al. Patient Experiences Following the OLFUS VIPES Phase IIb Epicutaneous Immunotherapy Trial: A Retrospective Qualitative Study. Annals of Allergy, Asthma & Immunology, Volume 123, Issue 5, S16
- Matthew Greenhawt, Joseph M. Chalil et al. Perceptions Among Peanut-Allergic Children: A Survey. Annals of Allergy, Asthma & Immunology, Volume 123, Issue 5, S16
- Begin P, Chalil J et al. Reduction in Severity Following 12 Months of Epicutaneous Immunotherapy for Peanut Allergy. Poster presentation; IWAA 2021, Intermountain West Allergy Association Annual Scientific Session.
- Greenhawt M, Chalil J, et al. Patient and Caregiver Burden of Peanut Allergy: An Ethnographic Study. Poster presentation; PAAM 2019, PEDIATRIC ALLERGY AND ASTHMA MEETING
- Chalil J, et al. (2019). HEALTHCARE RESOURCE USE (HCRU) AND COSTS ASSOCIATED WITH PEANUT ALLERGY (P.A.). Value in Health, Volume 22, S352. (Finalist for Research Poster Presentation Award at ISPOR 2019 in New Orleans).
- Pichurko, B. M., Chalil, Joseph, et al. (2001). Comparative value of single-breath diffusing capacity of carbon monoxide corrected for alveolar volume in COPD, Restrictive, and Normal individuals. American Journal of Respiratory and Critical Care Medicine, 163(5), A920.
- Pichurko, B., Chalil, Joseph, et al. (2002). The Significance of Cardiopulmonary Exercise Testing (CPX) on the management of Dyspnea in respiratory-impaired patients. American Journal of Respiratory and Critical Care Medicine, 165(8), A213.
Awards
- AAPI Presidential Award for Leadership 2023
- Selected as Top Physician of the Year for 2022 by the International Association of Top Professionals (IAOTP) for his outstanding leadership, dedication, and innovative medical contributions.
- Selected as one of eight World-Class Media Influencers by MSP news Global (2021)
- Recipient of the prestigious 2015 AAPI National Presidential Award.
- 2013 Outstanding Top 50 Asian Americans in Business Award
- New York Presidential Award - American Association of Physicians of Indian Origin (AAPI) regional conference in Westbury, New York (2013)
- American Association of Cardiologists of Indian Origin (AACIO) Honoree (2013)
- Boehringer Ingelheim President's Club winner for 2011 and 2014.
- Chalil was awarded the 2013 Outstanding Asian American in Business Award for his achievements in business at the 50 Asian Americans in Business Awards Gala. The award recognizes entrepreneurs for their role in driving the U.S. economy [2]
- The same year, he received the New York Presidential Award for his healthcare contributions during the American Association of Physicians of Indian Origin (AAPI) regional conference in Westbury, New York.[2]
- Chalil was also an American Association of Cardiologists of Indian Origin (AACIO) Honoree for his cardiology achievements in the field in 2013 [6]
- In 2015, Chalil was selected for Ashoka’s Executive in Residence Program (Cambridge, UK) by Boehringer, a key component of Ashoka and Boehringer Ingelheim’s partnership [4].
- He was also the Boehringer Ingelheim President's Club winner in 2011 and 2014.
- He is also the recipient of the prestigious 2015 AAPI National Presidential Award [6]
- He was selected as one of eight World-Class Media Influencers by MSP news Global [18].
References
- Dr. Joseph M. Chalil
- Dr. Joseph Chalil of BI Honored with Two Prestigious Awards in One Week
- Indo American Press Club holds virtual induction ceremony
- Dr. Joseph M. Chalil, M.D., M.B.A., FACHE
- Atossa Genetics Forms Strategic Advisory Board to Accelerate Growth
- Milestone Scientific Appoints Senior Pharmaceutical Industry Executive, Inventor and Physician Joseph M. Chalil to Global Advisory Board
- Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare
- Patents by Inventor Joseph M. Chalil
- Economic Burden of Disease Among Peanut-Allergic Children
- Patents
- OxySure (OXYS) Appoints Dr. Joseph M. Chalil to Strategic Advisory Board
- P302 ECONOMIC BURDEN OF DISEASE AMONG PEANUT-ALLERGIC CHILDREN
- D300 PATIENT EXPERIENCES FOLLOWING THE OLFUS VIPES PHASE IIB EPICUTANEOUS IMMUNOTHERAPY TRIAL: A RETROSPECTIVE QUALITATIVE STUDY
- D302 PERCEPTIONS AMONG PEANUT-ALLERGIC CHILDREN: A SURVEY
- PRS19 HEALTHCARE RESOURCE USE (HCRU) AND COSTS ASSOCIATED WITH PEANUT ALLERGIES (PA)
- Reporter Live
- Words Of Wisdom From 8 World-Class Media Influencers
- COVID offers chance for patient-centred healthcare change, new book argues
- Kirkus Book Review
- Joseph M. Chalil - Novo Integrated Scienes
- Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected As Top Physician Of The Year By IAOTP
- Dr. Joseph Chalil Honored Member Of IAOTP
- The Impact Of Allergy Specialty Care On Healthcare Utilization Among Peanut Allergy Children In The United States
- Peanut Cross-contamination In Randomly Selected Baked Goods
![](https://drchalil.com/wp-content/uploads/2023/12/Dr.-Joseph-M-Chalil-Signature-No-Photo-768x191.png)